Yufang Bi

机构：Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, National Health and Family Planning Commission, Ruijin Hospital, China National Bamboo Research Center, State Forestry and Grassland Administration, Fu Wai Hospital

发表论文 37 篇 · 总被引 814 次 · h-index 16

代表论文

• Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (2024 · New England Journal of Medicine · 被引 203)
• Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling (2023 · Gut Microbes · 被引 105)
• Causal relationships between the gut microbiome, blood lipids, and heart failure: a Mendelian randomization analysis (2023 · European Journal of Preventive Cardiology · 被引 66)
• Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials (2025 · The Lancet · 被引 38)
• Gut Microbiota‐Butyrate‐PPARγ Axis Modulates Adipose Regulatory T Cell Population (2025 · Advanced Science · 被引 27)
• Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes (2024 · Med · 被引 27)